Author:
Ho Pian Kamini,Nederstigt Monique
Reference47 articles.
1. A-Tjak, J., & De Groot, F. (2008). Acceptance and commitment therapy, een praktische handleiding voor hulpverleners. Stafleu van Loghum, Houten: Bohn.
2. Ball, S., Marangell, L. B., Lipsius, S., & Russell, J. M. (2013). Brain-derived neurotrophic factor in generalized anxiety disorder: Results from a duloxetine clinical trial. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 43, 217–221.
3. Buoli, M., Grassi, S., Serati, M., & Altamura, A. C. (2017). Agomelatine for the treatment of generalized anxiety disorder. Expert Opinion of Pharmacotherapy, 18(13), 1373–1379.
4. Cervena, K., Matousek, M., Prasko, J., Brunovsky, M., & Paskova, B. (2005). Sleep disturbances in patients treated for panic disorder. Sleep Medicine, 6, 149–153.
5. Coles, M. E., Johnson, E. M., & Schubert, J. R. (2011). Retrospective reports of the development of obsessive compulsive disorder: Extending knowledge of the protracted symptom phase. Behavioural Cognitive Psychotherapy, 39(5), 579–589.